No Prescription |
 |
 | ||
|
Noriday 28 Norethin |
|
| ||
No Prescription » Prescription Drugs 12 » Noriday 28 Norethin NORIDAY is a birth control pill commonly known as a "progestogen-only" pill or "mini pill". NORIDAY is usually given to women who are unable to take other types of birth control pills (combined oral contraceptives) or use intrauterine devices (IUDs).It is not known exactly how the "progestogen-only" pill works. However NORIDAY causes changes to the mucus of the cervix and the lining of the womb and affects the hormonal control system of the body which may all contribute to its effectiveness.The effectiveness of the "progestogen-only" pill is lower than that of other birth control pills.If taken according to directions it is expected that if 100 women used the progestogen-only pill for 1 year approximately 4 pregnancies may occur compared to less than 1 pregnancy in women using an oral contraceptive containing an oestrogen and progestogen.NORIDAY (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases.NORIDAY 28 day is only available on a prescription from your doctor.This medicine is prescribed for you and should not be given to others. Buy Noriday 28 Norethin and other Prescription Drugs 12 products online at Medstore. 5346
About Noriday 28 Norethin: Product Type: Prescription Drugs 12 Noriday 28 ( Norethin Generic Norethisterone ) Noriday 28 (Norethin Generic Norethisterone) Norethin Generic Norethisterone 350mcg 28 Tablets Norethin Generic Norethisterone Noriday 28
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
